edoxaban
Daiichi Sankyo
['cardio']
the envisage-tavi af trial, a study led by dr. , yielded the first risk score that can predict mortality for #atrialfibrillation patients who have undergone a successful transcatheter #aortic valve replacement: #cardiotwitter #esccongress 
Dedicated to the prevention, management, and eradication of cardiovascular disease, our team has invigorated the science of cardiovascular medicine. #MSHeart